Technical Analysis for CRBP - Corbus Pharmaceuticals Holdings, Inc.
Trend Table & Recent Alerts
|See historical CRBP trend table...|
|Date||Alert Name||Type||% Chg|
|Feb 16||Slingshot Bullish||Bullish Swing Setup||6.63%|
|Feb 16||Calm After Storm||Range Contraction||6.63%|
|Feb 15||Volume Surge||Other||6.63%|
|Feb 15||Shooting Star Candlestick||Bearish||6.63%|
|Feb 15||Lizard Bearish||Bearish Day Trade Setup||6.63%|
|Feb 15||Calm After Storm||Range Contraction||6.63%|
|Feb 14||Crossed Above 50 DMA||Bullish||5.36%|
|Feb 14||Stochastic Reached Overbought||Other||5.36%|
|Feb 13||50 DMA Resistance||Bearish||18.00%|
|Feb 13||Slingshot Bearish||Bearish Swing Setup||18.00%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
- Earnings date: 2017-03-27
Corbus Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel therapeutics to treat inflammatory-fibrotic diseases. The company primarily develops Resunab, an oral anti-inflammatory drug that has completed Phase I clinical trials for the treatment of cystic fibrosis and diffuse scleroderma. It sells its products through hearing professionals, including audiologists, hearing aid specialists, and ENT doctors worldwide. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Is CRBP a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more CRBP news...
|52 Week High||10.78|
|52 Week Low||1.21|
|200-Day Moving Average||5.52|
|50-Day Moving Average||7.72|
|20-Day Moving Average||7.08|
|10-Day Moving Average||7.39|
|Average True Range||0.62|
|Chandelier Exit (Long, 3 ATRs)||7.34|
|Chandelier Exit (Short, 3 ATRs)||8.01|
|Upper Bollinger Band||8.61|
|Lower Bollinger Band||5.55|
|Percent B (%b)||1.08|